Form Filed By Welgus Howard G.
Wed, Jun 18, 2025
Go to original document
Arcutis Biotherapeutics, Inc. (ARQT)
Healthcare
Biotechnology
Insights
Coming soon
Non Derivative Transactions
2025-06-18
Common Stock
Sale
S
Type
Disposed 10,139 shares @ $13.37 per share
109,414 shares
Direct
Footnotes
1. The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2025, by the Reporting Person, with a plan end date of May 29, 2026.
2. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.2118 to $13.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.